Home » Topics » Regulatory » Patents

Patents
RSS

Dopamine receptor subtype-specific ligands prepared at Neurogen

Dec. 2, 1997

Almirall discloses new COX-2-selective compounds

Dec. 2, 1997

Novel adenosine antagonists revealed by Fujisawa

Dec. 2, 1997

Heterocyclic antitumor agents from Dainippon

Dec. 2, 1997

Steroidal anticancer compounds isolated from C. africana

Dec. 2, 1997

Fujisawa isolates novel calpain inhibitors

Dec. 2, 1997

U.S. patent covers new melanoma antigen/MAb discovered by Cytoclonal

Dec. 1, 1997

Bayer focuses on agents for atherosclerosis

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

AHP describes new compounds with tissue-selective estrogenic and antiestrogenic effects

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...